Research ArticlePediatrics
MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma
C. Jaimes, S. Vajapeyam, D. Brown, P.-C. Kao, C. Ma, L. Greenspan, N. Gupta, L. Goumnerova, P. Bandopahayay, F. Dubois, N.F. Greenwald, T. Zack, O. Shapira, R. Beroukhim, K.L. Ligon, S. Chi, M.W. Kieran, K.D. Wright and T.Y. Poussaint
American Journal of Neuroradiology May 2020, 41 (5) 874-881; DOI: https://doi.org/10.3174/ajnr.A6546
C. Jaimes
aFrom the Departments of Radiology (C.J., S.V., T.Y.P.)
cFetal-Neonatal Neuroimaging and Developmental Science Center (C.J.), Division of Newborn Medicine; Boston Children’s Hospital, Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
S. Vajapeyam
aFrom the Departments of Radiology (C.J., S.V., T.Y.P.)
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
D. Brown
dTumor Imaging Metrics Core (D.B.), Massachusetts General Hospital, Boston, Massachusetts
P.-C. Kao
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
C. Ma
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
L. Greenspan
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
N. Gupta
fDepartment of Pediatric Neurosurgery (N.G.), University of California San Francisco Benioff Children’s Hospital, San Francisco, California
jUniversity of California San Francisco School of Medicine (N.G., T.Z.), San Francisco, California
L. Goumnerova
P. Bandopahayay
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
F. Dubois
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
N.F. Greenwald
kStanford University School of Medicine (N.F.G.), Palo Alto, California
T. Zack
jUniversity of California San Francisco School of Medicine (N.G., T.Z.), San Francisco, California
O. Shapira
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
lBroad Institute of Massachusetts Institute of Technology and Harvard University (O.S.), Cambridge, Massachusetts.
R. Beroukhim
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
K.L. Ligon
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
hDepartment of Pathology (K.L.L.), Brigham and Women’s Hospital, Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
S. Chi
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
M.W. Kieran
gClinical Trials Division (M.W.K.), Bristol-Myers-Squibb, New York, New York
K.D. Wright
bPediatrics, Division of Oncology (P.-C.K., C.M., L.G., P.B., R.B., S.C., K.D.W.)
eDana Farber Cancer Institute (P.-C.K., C.M., L.G., P.B., F.D., O.S., R.B., K.L.L., S.C., K.D.W.), Boston, Massachusetts
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
T.Y. Poussaint
aFrom the Departments of Radiology (C.J., S.V., T.Y.P.)
iHarvard Medical School (C.J., S.V., C.M., P.B., F.D., R.B., K.L.L., S.C., K.D.W., T.Y.P.), Boston, Massachusetts
Advertisement